Teva Announces Nationwide Opioids Settlement to Move Forward After Receiving Broad Support from States | Business Wire
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State | CNN
Teva Wins Ruling Tossing $235 Million Glaxo Drug Verdict - Bloomberg
Do Analysts Expect Teva Pharmaceutical Industries Ltd (TEVA) Stock to Rise After It Has Gained 10.21% in a Month?
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Teva Pharmaceutical Industries Limited (TEVA) Stock Price, Quote & News - Stock Analysis
Teva Pharmaceutical Stock Could Double | Barron's
Teva Pharmaceuticals - Wikipedia
Teva's two new digital inhalers complete Digihaler product line | MobiHealthNews
Teva Pharmaceuticals Q4 2016 Earnings
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceuticals Found Liable in Landmark Opioid Trial - The New York Times
Teva Stock: Teva Guides To Its First Year Of Growth Since 2017, But There's A Caveat | Investor's Business Daily
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva Pharmaceuticals resolves bribery case with Israel authorities | The FCPA Blog
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceuticals will pay $420 million in a federal case
